800-845-6913
Tuteur & Associates, LLC | Knowledge is Power.
February 26, 2007
February 2007 West Haven, CT, USA. – Bayer has conducted a preliminary review of the observational study entitled “Mortality Associated with Aprotinin During 5 Years Following Coronary Artery Bypass Graft Surgery” by Mangano et al. as well as the editorial by T. Bruce Ferguson, Jr., MD from the East Carolina University, Greenville, NC, scheduled for publication on February 7, 2007 in the Journal of the American Medical Association (JAMA) regarding long-term mortality rates in coronary artery bypass graft surgery patients including those treated with aprotinin. Continue reading, ‘02-26-2007 | Bayer Responds to study and commentary published in Journal of American Medical Association (JAMA).’